Live Breaking News & Updates on Analyst Recommendations For Jazz Pharmaceuticals

Stay updated with breaking news from Analyst recommendations for jazz pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Receives Average Recommendation of "Moderate Buy" from Analysts

Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Rating) has been given a consensus rating of “Moderate Buy” by the twelve analysts that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that […] ....

Brucec Cozadd , Kim Sablich , Prudential Financial Inc , Hennion Walsh Asset Management Inc , Allspring Global Investments Holdings , Needham Company , Envestnet Asset Management Inc , Insider Activity At Jazz Pharmaceuticals , News Ratings For Jazz Pharmaceuticals Daily , Td Asset Management Inc , Jazz Pharmaceuticals Plc , Analyst Recommendations For Jazz Pharmaceuticals , Institutional Trading Of Jazz Pharmaceuticals , Goldman Sachs Group , Jazz Pharmaceuticals Price Performance , Jazz Pharmaceuticals , Get Rating , Asset Management , Walsh Asset Management , Global Investments Holdings , Pharmaceuticals Plc , Jazz Pharmaceuticals Daily , Nasdaq Jazz ,

The Goldman Sachs Group Increases Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target to $170.00

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock. ....

United States , Brucec Cozadd , Samantha Pearce , Morgan Stanley , Jazz Pharmaceuticals Company Profile , Securities Exchange Commission , Jazz Pharmaceuticals Stock Performance , Jazz Pharmaceuticals , Impax Asset Management Group , Analyst Recommendations For Jazz Pharmaceuticals , Guggenheim Capital , News Ratings For Jazz Pharmaceuticals Daily , Squarepoint Ops , Goldman Sachs Group , Itau Unibanco Holding , Institutional Trading Of Jazz Pharmaceuticals , Get Rating , Stock Target Advisor , Exchange Commission , Asset Management Group , Adage Capital Partners , Capital Partners , Target Advisor , Jazz Pharmaceuticals Daily ,

Jazz Pharmaceuticals (NASDAQ:JAZZ) Downgraded by StockNews.com

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Rating) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a report issued on Friday. Several other research firms have also weighed in on JAZZ. Cowen lifted their price objective on shares of Jazz Pharmaceuticals from $200.00 to $225.00 in a research note on Thursday, May […] ....

United States , Patricia Carr , Brucec Cozadd , Piper Sandler , National Bank , Securities Exchange Commission , Lloyd Advisory Services , Capital Group , Jazz Pharmaceuticals , Analyst Recommendations For Jazz Pharmaceuticals , Cantor Fitzgerald , Jazz Pharmaceuticals Get Rating , Quent Capital , Get Rating , Exchange Commission , Advisory Services , Elequin Capital , Nasdaq Jazz , Stocknews Com ,

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Average Rating of "Buy" by Brokerages

Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Get Rating) has received an average rating of “Buy” from the eighteen analysts that are presently covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and nine have issued a buy recommendation on the company. The average 1-year price objective among analysts that […] ....

United States , Patricia Carr , Anne Oriordan , Piper Sandler , Morgan Stanley , First Republic Investment Management Inc , Securities Exchange Commission , Manufacturers Life Insurance Company , Jazz Pharmaceuticals , Analyst Recommendations For Jazz Pharmaceuticals , Oppenheimer Asset Management Inc , Needham Company , Cantor Fitzgerald , Jazz Pharmaceuticals Get Rating , Get Rating , Marketbeat Ratings , Exchange Commission , Director Anne Oriordan , Asset Management Gmbh , Republic Investment Management , Asset Management , Nasdaq Jazz ,

Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock Rating Upgraded by StockNews.com

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Rating) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Saturday. Several other equities analysts also recently issued reports on the stock. Truist Financial upped their price objective on shares of Jazz Pharmaceuticals from $180.00 to $200.00 in a research note […] ....

United States , Brucec Cozadd , Piper Sandler , Securities Exchange Commission , Goldman Sachs Group Inc , Jazz Pharmaceuticals , Norges Bank , Analyst Recommendations For Jazz Pharmaceuticals , Jazz Pharmaceuticals Company Profile Get Rating , Polaris Capital Management , Farallon Capital Management , Goldman Sachs Group , Get Rating , Exchange Commission , Sachs Group , Capital Management , Pharmaceuticals Company Profile , Nasdaq Jazz , Stocknews Com ,